These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 25424249)
1. Differences in attitude toward adjuvant chemotherapy between colorectal cancer survivors and the medical staff of Japanese hospitals. Narita Y; Taniguchi H; Komori K; Kimura K; Kinoshita T; Komori A; Nomura M; Kadowaki S; Takahari D; Ura T; Andoh M; Muro K Int J Clin Oncol; 2015 Aug; 20(4):755-60. PubMed ID: 25424249 [TBL] [Abstract][Full Text] [Related]
2. [A questionnaire survey on QOL and toxicity in colorectal cancer survivors who received adjuvant chemotherapy]. Taniguchi H; Narita Y; Komori K; Kimura K; Kinoshita T; Komori A; Uegaki S; Nomura M; Nitta S; Yamaguchi K; Kadowaki S; Takahari D; Ura T; Andoh M; Muro K Gan To Kagaku Ryoho; 2015 Apr; 42(4):457-61. PubMed ID: 25963692 [TBL] [Abstract][Full Text] [Related]
3. Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colorectal cancer: JSWOG-C2 study. Tsuruta A; Yamashita K; Tanioka H; Tsuji A; Inukai M; Yamakawa T; Yamatsuji T; Yoshimitsu M; Toyota K; Yamano T; Nagasaka T; Okajima M Drug Des Devel Ther; 2016; 10():3827-3835. PubMed ID: 27920498 [TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer surgery in portal hypertensive patients: does adjuvant oxaliplatin affect prognosis? Madbouly KM; Hussein AM; Zeid A Dis Colon Rectum; 2013 May; 56(5):577-85. PubMed ID: 23575396 [TBL] [Abstract][Full Text] [Related]
5. Peripheral neuropathy in colorectal cancer survivors: the influence of oxaliplatin administration. Results from the population-based PROFILES registry. Beijers AJ; Mols F; Tjan-Heijnen VC; Faber CG; van de Poll-Franse LV; Vreugdenhil G Acta Oncol; 2015 Apr; 54(4):463-9. PubMed ID: 25417732 [TBL] [Abstract][Full Text] [Related]
6. [Tolerability of Oxaliplatin-Based Adjuvant Chemotherapy for Patients with Colorectal Cancer]. Matsuo H; Nakanishi M; Arita T; Murayama Y; Kuriu Y; Kosuga T; Konishi H; Morimura R; Komatsu S; Shiozaki A; Ikoma H; Ichikawa D; Fujiwara H; Okamoto K; Otsuji E Gan To Kagaku Ryoho; 2015 Nov; 42(12):2112-4. PubMed ID: 26805281 [TBL] [Abstract][Full Text] [Related]
7. Incidence of chemotherapy-induced amenorrhea in premenopausal women treated with adjuvant FOLFOX for colorectal cancer. Cercek A; Siegel CL; Capanu M; Reidy-Lagunes D; Saltz LB Clin Colorectal Cancer; 2013 Sep; 12(3):163-7. PubMed ID: 23871161 [TBL] [Abstract][Full Text] [Related]
8. N-acetylcysteine has neuroprotective effects against oxaliplatin-based adjuvant chemotherapy in colon cancer patients: preliminary data. Lin PC; Lee MY; Wang WS; Yen CC; Chao TC; Hsiao LT; Yang MH; Chen PM; Lin KP; Chiou TJ Support Care Cancer; 2006 May; 14(5):484-7. PubMed ID: 16450089 [TBL] [Abstract][Full Text] [Related]
9. A Study on the Tolerability of Capecitabine plus Oxaliplatin as Adjuvant Chemotherapy. Nakanishi M; Kuriu Y; Murayama Y; Arita T; Kosuga T; Morimura R; Konishi H; Komatsu S; Shiozaki A; Ikoma H; Ichikawa D; Fujiwara H; Okamoto K; Otsuji E Anticancer Res; 2016 Apr; 36(4):1851-4. PubMed ID: 27069169 [TBL] [Abstract][Full Text] [Related]
10. Oxaliplatin-induced peripheral neuropathy's effects on health-related quality of life of colorectal cancer survivors. Tofthagen C; Donovan KA; Morgan MA; Shibata D; Yeh Y Support Care Cancer; 2013 Dec; 21(12):3307-13. PubMed ID: 23903798 [TBL] [Abstract][Full Text] [Related]
12. Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed? Simes RJ; Coates AS J Natl Cancer Inst Monogr; 2001; (30):146-52. PubMed ID: 11773309 [TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life in early breast cancer. Groenvold M Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of oxaliplatin-based chemotherapy in curatively resected colorectal cancer with liver metastasis. Kim HR; Min BS; Kim JS; Shin SJ; Ahn JB; Rho JK; Kim NK; Rha SY Oncology; 2011; 81(3-4):175-83. PubMed ID: 22057187 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of CpG Island Methylator Phenotype as a Biomarker in Colorectal Cancer Treated With Adjuvant Oxaliplatin. Cohen SA; Wu C; Yu M; Gourgioti G; Wirtz R; Raptou G; Gkakou C; Kotoula V; Pentheroudakis G; Papaxoinis G; Karavasilis V; Pectasides D; Kalogeras KT; Fountzilas G; Grady WM Clin Colorectal Cancer; 2016 Jun; 15(2):164-9. PubMed ID: 26702772 [TBL] [Abstract][Full Text] [Related]
17. Large Colorectal Carcinoma Is Predictive of Recurrence After Adjuvant Chemotherapy Using Oxaliplatin. Nozawa H; Nishikawa T; Tanaka T; Tanaka J; Kiyomatsu T; Kawai K; Hata K; Kazama S; Yamaguchi H; Ishihara S; Sunami E; Kitayama J; Watanabe T Anticancer Res; 2015 Sep; 35(9):5073-8. PubMed ID: 26254409 [TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of interhospital variation in adjuvant chemotherapy for patients with Stage II/III colorectal cancer: a nationwide study. Arakawa K; Kawai K; Tanaka T; Hata K; Sugihara K; Nozawa H Colorectal Dis; 2018 Jul; 20(7):O162-O172. PubMed ID: 29752849 [TBL] [Abstract][Full Text] [Related]
19. Survey of oxaliplatin-associated neurotoxicity using an interview-based questionnaire in patients with metastatic colorectal cancer. Leonard GD; Wright MA; Quinn MG; Fioravanti S; Harold N; Schuler B; Thomas RR; Grem JL BMC Cancer; 2005 Sep; 5():116. PubMed ID: 16168057 [TBL] [Abstract][Full Text] [Related]
20. Microsatellite instability in the management of stage II colorectal patients. Strâmbu V; Garofil D; Pop F; Radu P; Brătucu M; Iorga C; Iorga R; Pasnicu C; Ion A; Popa F Chirurgia (Bucur); 2013; 108(6):816-21. PubMed ID: 24331320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]